KVUE

Kenvue Inc.

Consumer DefensiveHousehold & Personal ProductsNASDAQ

$17.28

-$0.18 (-1.03%)today

Conviction

0/ 10

Fair Value$19.83

Upside+14.78%

Signal0

Market Cap$32.5B

52W Range$14.02–$25.17

Next EarningsMay 7

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$19.63

Current Price$17.40

Upside / Down+12.8%

P(Undervalued)70.5%

P(20%+ Up)39.7%

P(15%+ Down)11.7%

Fair Value Distribution — percentile bands

70.5% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

-1.6%/yr

±4.1% · revenue growth to justify current price

FCF-Based Reverse DCF

0.4%/yr

±3.2% · FCF growth to justify current price

THE GAP

Market pricing margin compression or rising capex

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Quick Take

Kenvue Inc.

Trailing P/E22.3x

Forward P/E14.0x

P/S2.1x

EPS (TTM)$0.76

Analyst Target$19.83

Analyst Upside14.8%

No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10kMar 2

Conviction: unchanged

KVUE FY2025 10-K: Separation Stabilization, Merger Uncertainty

KVUE FY2025: Largest pure-play consumer health company emerging from J&J separation and entering K-C merger. Strong brand moat but faces retail consolidation, product liability, and regulatory headwin...